Resultado da Busca
Daniel Lucius Vasella (born 15 August 1953) is a Swiss medical doctor, author, and executive who was CEO and chairman of the Swiss pharmaceutical company Novartis AG, the world's fifth largest drug company. During his tenure Novartis shares fell 10%, compared to the industry average.
2 de mai. de 2024 · Daniel Vasella, Swiss doctor and businessman who served as chairman (1999–2013) and CEO (1996–2010) of the pharmaceutical company Novartis. Learn more about Vasella’s life and career, including information about his tenure at Novartis as well as his other board memberships.
1 de set. de 2012 · Daniel Vasella, former CEO of Novartis, shares his insights on leading in the 21st century. He discusses the challenges and opportunities of global health care, the role of innovation and compliance, and the importance of resilience and communication.
1 de mar. de 2007 · Although initially regarded by critics as too inexperienced to lead a multinational pharmaceutical company, Vasella has triumphed. Three years ago he was named “the most influential European businessman of the past 25 years” in a Financial Times poll of 4,000 executives.
1 de jan. de 2003 · Dan Vasella has experienced first-hand the anguish of seriously ill patients and their families-first when he lost an older sister to lymphoma and later as a practicing physician in his native Switzerland.
1 de jul. de 2009 · Dan Vasella, CEO and chairman of Novartis AG, leads off our video interview series McKinsey conversations with global leaders. This ongoing project explores vital management issues, industry insights, and topical analysis with CEOs of today’s leading global companies.
19 de jan. de 2005 · BBC News business reporter in Basel, Switzerland. Daniel Vasella is in reflective mood. When you experience disease and death early on, you realise that time is not endless. As chairman and...
